In the light of other experiments it is postulated that there exists a "threshold" in the dose of a hypnotic, and that when this is exceeded the drug will produce R.E.M. reduction. Thus it may be possible to prescribe a drug which is clinically useful while avoiding withdrawal effects.
Introduction
The great expansion during the past 15 years of information on the measurement of sleep has prompted further research into the effects of hypnotic drugs (Oswald and Priest, 1965; Kales et al., 1968 Kales et al., , 1969 .
Sleep is composed of two regularly alternating physiological states: (1) orthodox sleep, characterized by regularity of physiological indices and relative absence of mental activity, and (2) paradoxical or rapid eye movement (R.E.M.) sleep, in which there is great irregularity of many physiological measures and in which the bulk of dreaming occurs (Dement and Kleitman, 1957; Jouvet, 1967) . Orthodox sleep is further divided into four stages, and during much of adult life R.E.M. sleep is usually found to occupy about 24% of total sleep.
Sodium amylobarbitone has been the drug most used to examine the effects of a barbiturate on sleep (Oswald and Priest, 1965; . In clinical doses it produced an immediate alteration in the relationship of orthodox sleep to R.E.M. sleep. Orthodox sleep was enhanced and there was considerable depression of R.E.M. sleep. During continued administration the amount of R.E.M. sleep approximated towards baseline values-a "tolerance" phenomenon. Stop- ping the drug produced a fluctuant excess of R.E.M. sleep which subsided over several weeks-a "rebound" phenomenon-and in the larger dose experiments this R.E.M. sleep excess was associated with nightmares (Oswald and Priest, 1965) . This persistent state may explain the difficulties experienced in withdrawing the drug in some patients.
Though many patients may continue with the drug for long periods without attendant difficulties (Johnson and Clift, 1968) , it would seem desirable that hypnotics should be free from withdrawal effects if this is possible.
The effects of various non-barbiturate hypnotics on sleep have been studied, but results are conflicting. Oswald and Priest (1965) sleep. Lehmann and Ban (1968) found that chloral hydrate (650 mg.) disturbed R.E.M. sleep insignificantly in comparison with quinalbarbitone (secobarbital) (100 mg.) or nitrazepam (10 mg.). These observations raise some questions in relation to a current theory of drug withdrawal delirium (Gross et al., 1966; Greenberg and Pearlman, 1967) . Drugs which on withdrawal can give rise to delirium-that is, alcohol, barbiturates and other hypnotics, meprobamate-have all been shown to produce R.E.M. depression and to be associated with an R.E.M. rebound in withdrawal (Gresham et al., 1963; Oswald et al., 1969) . It is an old observation (de Clerambault, 1910 ) that when chloral hydrate was withdrawn from addicts delirium resulted. This strongly suggests that chloral hydrate disturbs R.E.M. sleep.
In view of these conflicts two separate experiments were arranged to examine the effects of clinical doses of chloral hydrate, dichloralphenazone, and Mandrax (methaqualone 250 mg. and diphenhydramine 25 mg.).
Method
The experimental design follows closely that used to examine the effects of sodium amylobarbitone in clinical doses .
Four healthy men aged 21 to 26 were used in each experiment. Throughout the experimental period, six to eight weeks, they were instructed to refrain from alcohol and any medication and to keep regular hours when not recorded. The first recorded night in the laboratory was regarded as a "habituation" night (Mendels and Hawkins, 1967 ) and discarded. A series of six nights taken at intervals over a fortnight were used as baseline data. Five to eight intermittent night recordings were taken when the subjects were on hypnotics, and a similar number of recordings were obtained in the withdrawal period (for details see Table I and II) .
On a recording night subjects reported to the laboratory at 22.30 hours. Silver disc electrodes were attached round the Sleep and Hypnoticseyes, to the scalp in the midline, and under the chin as described elsewhere Kales, 1968 311 during the first two or three nights on the drug, and this depression was found to be significant at the 0.5 level (t=13-6222) with the statistical procedure outlined previously amylobarbitone (Akindele et al., 1970) , chlorpromazine , and chlormethiazole . The existence of such a threshold varying in individuals may explain the conflicting results obtained from various studies of non-barbiturate hypnotics. The absence of a consistent R.E.M. sleep rebound when these hypnotics were stopped supports the fact that R.E.M. sleep is only minimally affected by clinical doses of these hypnotics. In itself it is not an absolute indication that op clinical withdrawal complaints arose. In this study, however, it was found that no definite disturbance of slow-wave sleep occurred when the drugs were stopped.
An excess of R.E.M. sleep and a disturbance of slow-wave sleep can be tolerated by subjects without definite complaint , but if the increase in R.E.M. sleep is severe and intense, nightmares occur, as Oswald and Priest (1965) showed when sodium amylobarbitone (600 mg.) was withdrawn. Kales and Jacobson (1967) recordetd nightmares when methyprylone (300 mg.) was stopped. Comparison of the studies of sodium amylobarbitone 200 mg. and 600 mg. (Oswald and Priest, 1965) procedure and O'Malley (1959) suggested that release of the iliopsoas muscle was a more important factor. Layani, Cordier, Garnier, Roeser, and Paquet (1959) injected 1% lignocaine into various sites of proposed muscle division and found that the greatest relief of pain occurred from injection around the insertion of the iliopsoas. They followed this with a clinical trial of osteotomy of the lesser trochanter added to the Voss procedure (Cordier, Layani, and Gamier, 1960 
Results
The results have been analysed in three groups, according to the aetiology. The results were assessed by considering relief of pain, functional activity, movement of the hip, and radiographic appearances.
Relief of pain.-Pain was the main reason for operation. The relief of pain has been classified into complete relief, partial relief, and no relief (Table I) . Patients with complete relief were free from pain from the time of operation to follow-up. Those with partial relief were initially pain-free and then had recurrence; the average time of recurrence was one year after operation. In the two cases of rheumatoid arthritis pain recurred at 12 and 14 months; this pain was less than before operation and neither patient felt that further treatment was necessary. 
